Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: Evaluating efficacy, safety, and improvement in quality of life

Drug Design, Development and Therapy

Volumn 8, Issue , 2014, Pages 497-503

  Guo, Su Ping ^a   Wu, San Gang ^b   Zhou, Juan ^b   Feng, Hui Xia ^a   Li, Feng Yan ^a   Wu, Ying Jia ^a   Sun, Jia Yuan ^a   He, Zhen Yu ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

Mucositis; Nasopharyngeal cancer; Noncancerous pain; Quality of life; Transdermal fentanyl

Indexed keywords

CISPLATIN; FENTANYL; FLUOROURACIL; PACLITAXEL;

ADULT; ADVANCED CANCER; ANALGESIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL EVALUATION; CLINICAL TRIAL; CONSTIPATION; DISEASE SEVERITY; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MOUTH PAIN; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NAUSEA; ORAL MUCOSITIS; PAIN ASSESSMENT; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION INJURY; RASH; SCORING SYSTEM; TRANSDERMAL PATCH; TREATMENT OUTCOME; VOMITING; CHEMICALLY INDUCED; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PAIN; PATHOPHYSIOLOGY; PSYCHOLOGY; STOMATITIS;

ADMINISTRATION, CUTANEOUS; ADULT; CHEMORADIOTHERAPY; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PAIN; PROSPECTIVE STUDIES; QUALITY OF LIFE; STOMATITIS;

EID: 84900399144     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Liu Q, Chen JO, Huang QH, Li YH. Trends in the survival of patients with nasopharyngeal carcinoma between 1976 and 2005 in Sihui, China: a population-based study. Chin J Cancer. 2013;32(6):325-333.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
3. Mao Y P, Liang SB, Liu LZ, et al. The N staging system in nasopharyn-geal carcinoma with Radiation Therapy Oncology Group guidelines for lymph node levels based on magnetic resonance imaging. Clin Cancer Res. 2008;14(22):7497-7503.
4. Chen Y, Sun Y, Liang SB, et al. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemo-radiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China. Cancer. 2013;119(12):2230-2238.
5. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16(4): 1310-1317.
6. Lee AW, Tung SY, Ngan RK, et al. Factors contributing to the effcacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 trials. Eur J Cancer. 2011;47(5):656-666.
7. Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol. 2005;23(27):6730-6738.
8. Worthington H V, Clarkson JE, Bryan G, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2011;(4):CD000978.
9. Peterson DE, Bensadoun RJ, Roila F, et al. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22(Suppl 6):vi78-vi84.
10. Hong J P, Lee SW, Song SY, et al. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies. Eur J Cancer Care (Engl). 2009;18(6):636-641.
11. Naidu MU, Ramana G V, Rani PU, Mohan IK, Suman A, Roy P. Chemotherapy-induced and/or radiation therapy-induced oral mucosi-tis - complicating the treatment of cancer. Neoplasia. 2004;6(5): 423-431.
12. Saroja G, Devi PS, Namrata R. Oral morphine solution as an oral rinse or mouth gargle for mucositis pain. Indian J Palliat Care. 2010;16(1):54-55.
13. Saunders D P, Epstein JB, Elad S, et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3191-3207.
14. Peterson DE, Bensadoun RJ, Roila F. Management of oral and gastrointestinal mucositis: ESMO clinical recommendations. Ann Oncol. 2008;19 Suppl 2:ii122-ii125.
15. Chen WH, Liu K, Tan PH, Chia Y Y. Effects of postoperative background PCA morphine infusion on pain management and related side effects in patients undergoing abdominal hysterectomy. J Clin Anesth. 2011;23(2):124-129.
16. Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic effcacy in chronic cancer pain control. Drugs. 2001;61(15):2289-2307.
17. Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, effcacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage. 1997;13(5):254-261.
18. Chang JT, Lin CY, Lin JC, Lee MS, Chen YJ, Wang HM. Transdermal fentanyl for pain caused by radiotherapy in head and neck cancer patients treated in an outpatient setting: a multicenter trial in Taiwan. Jpn J Clin Oncol. 2010;40(4):307-312.
19. National Cancer Institute. Common terminology criteria for adverse events v3.0 (CTCAE). 2006. Available from: http://ctep.cancer.gov/pro-tocolDevelopment/electronic_applications/docs/ctcaev3.pdf. Accessed May 21, 2008.
20. International Commission on Radiation Units and Measurements (ICRU). Prescribing, Recording and Reporting Photon Beam Therapy. ICRU Report 50. Bethesda: ICRU; 1993.
21. International Commission on Radiation Units and Measurements (ICRU). Prescribing, Recording and Reporting Photon Beam Therapy [supplement to ICRU Report 50]. ICRU Report 62. Bethesda: ICRU; 1999.
22. Farzana M, Shahead C, Buettner P. Measuring clinical outcomes of chronic pain patients. 2011. Available from: http://www.practicalpainmanagement.com/resources/diagnostic-tests/measuring-clinical-outcomes-chronic-pain-patients. Accessed December 12, 2013.
23. van Seventer R, Smit JM, Schipper RM, et al. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. Curr Med Res Opin. 2003;19(6):457-469.
24. Minkowitz HS, Rathmell J P, Vallow S, Gargiulo K, Damaraju C V, Hewitt DJ. Effcacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery. Pain Med. 2007;8(8):657-668.
25. Tawfk MO, Bryuzgin V, Kourteva G. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain. Curr Med Res Opin. 2004;20(3):259-267.
26. Pillitteri LC, Clark RE. Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplant. 1998;22(5):495-498.
27. Strupp C, Sudhoff T, Germing U, et al. Transdermal fentanyl during high-dose chemotherapy and autologous stem cell support. Oncol Rep. 2000;7(3):659-661.
28. Kim JG, Sohn SK, Kim DH, et al. Effectiveness of transdermal fenta-nyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation. Transplant Proc. 2005;37(10): 4488-4491.
29. Demarosi F, Lodi G, Soligo D, et al. Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain. Bone Marrow Transplant. 2004;33(12): 1247-1251.
30. Cai Q, Huang H, Sun X, et al. Effcacy and safety of transdermal fentanyl for treatment of oral mucositis pain caused by chemotherapy. Expert Opin Pharmacother. 2008;9(18):3137-3144.
31. Stiff P, Mumby P, Miler L, et al. Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis. Bone Marrow Transplant. 2006;38(11):757-764.
32. Clark AJ, Ahmedzai SH, Allan LG, et al. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin. 2004;20(9):1419-1428.